The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults.


Journal

Cleveland Clinic journal of medicine
ISSN: 1939-2869
Titre abrégé: Cleve Clin J Med
Pays: United States
ID NLM: 8703441

Informations de publication

Date de publication:
02 11 2020
Historique:
entrez: 3 11 2020
pubmed: 4 11 2020
medline: 16 7 2021
Statut: epublish

Résumé

Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

Identifiants

pubmed: 33139263
pii: 87/11/695
doi: 10.3949/ccjm.87a.20056
doi:

Substances chimiques

Antirheumatic Agents 0
Immunosuppressive Agents 0
Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

695-703

Informations de copyright

Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Auteurs

Alvin Lee Day (AL)

Clinical Assistant Professor, Division of Rheumatology, Palmetto Health/University of South Carolina School of Medicine, Columbia, SC.

Kevin L Winthrop (KL)

Professor, Division of Infectious Diseases, Oregon Health and Science University, Portland, OR.

Jeffrey R Curtis (JR)

Professor, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL jrcurtis@uabmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH